1,2-dithiolane compounds
    42.
    发明授权
    1,2-dithiolane compounds 失效
    1,2-二硫戊环化合物

    公开(公告)号:US6150358A

    公开(公告)日:2000-11-21

    申请号:US460596

    申请日:1999-12-14

    CPC分类号: C07D339/04

    摘要: A compound of formula (I): ##STR1## wherein Ra represents linear or branched (C.sub.1 -C.sub.8)alkylene,Rb represents single bond, or linear or branched (C.sub.1 -C.sub.6)alkylene,Z represents thiocarbamate, or thioamide, each being optionally substituted,T represents optionally substituted morpholino,its isomers, and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same which are useful in the treatment of disease for which the use of anti-oxidation agent is required.

    摘要翻译: 式(I)化合物:其中Ra表示直链或支链(C1-C8)亚烷基,Rb表示单键,或直链或支链(C1-C6)亚烷基,Z表示硫代氨基甲酸盐或硫代酰胺,各自任选被取代,T 表示任选取代的吗啉代,其异构体和药学上可接受的酸或碱加成盐,以及含有该取代基的药物制剂,其可用于治疗需要使用抗氧化剂的疾病。

    2-(1H) quinolinone compounds
    43.
    发明授权
    2-(1H) quinolinone compounds 失效
    2-(1H)喹啉酮化合物

    公开(公告)号:US5776949A

    公开(公告)日:1998-07-07

    申请号:US889920

    申请日:1997-07-10

    摘要: A compound of formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3, which are identical or different, represent hydrogen, halogen, alkyl, nitro, cyano, aminosulfonyl, imidazolyl, or pyrrolyl, or alternatively, when two of them are situated on adjacent carbons, may form with the carbon atoms to which they are attached a benzene ring on C.sub.3 -C.sub.7 cyloalkyl R.sub.4 represents hydroxyl, alkoxy, phenoxy, or amino, their isomers as well as their addition salts with a pharmaceutically-acceptable base, and medicinal products containing the same which are useful as inhibitors of the the pathological phenomena linked to hyperactivation of the neurotransmission pathways by the excitatory amino acids.

    摘要翻译: 式(I)化合物:其中:R 1,R 2,R 3相同或不同,表示氢,卤素,烷基,硝基,氰基,氨基磺酰基,咪唑基或吡咯基,或者, 当它们中的两个位于相邻的碳上时,可以与它们所连接的碳原子一起形成C3-C7环烷基上的苯环R4表示羟基,烷氧基,苯氧基或氨基,它们的异构体以及它们与 药学上可接受的碱和含有它们的药物,其可用作与兴奋性氨基酸对神经传递途径的过度活化有关的病理现象的抑制剂。

    Phenylpyridylpiperazine compounds
    47.
    发明授权
    Phenylpyridylpiperazine compounds 失效
    苯基吡啶基哌嗪化合物

    公开(公告)号:US07494995B2

    公开(公告)日:2009-02-24

    申请号:US11432787

    申请日:2006-05-11

    CPC分类号: C07D213/74

    摘要: A compound selected from those of formula (I): wherein: R1 represents an NR3SO2R4 group wherein: R3 represents a hydrogen atom or an alkyl group, R4 represents an alkyl group, aryl group or NR5R6 group, R2 represents an alkyl, cycloalkyl or cycloalkylalkyl group, and medicinal products containing the same which are useful in treating conditions treatable by antagonists of type H3 central histamine receptors.

    摘要翻译: 选自式(I)的化合物:其中:R1表示NR3SO2R4基团,其中:R3表示氢原子或烷基,R4表示烷基,芳基或NR5R6基团,R2表示烷基,环烷基或环烷基烷基 组和含有该组合物的药物,可用于治疗由H3型中枢组胺受体的拮抗剂治疗的病症。

    Phenylpyridylpiperazine compounds
    48.
    发明授权
    Phenylpyridylpiperazine compounds 失效
    苯基吡啶基哌嗪化合物

    公开(公告)号:US07494994B2

    公开(公告)日:2009-02-24

    申请号:US11432250

    申请日:2006-05-11

    CPC分类号: C07D213/74

    摘要: A compound selected from those of formula (I): wherein: X represents a C(O) or SO2 group, R1 represents an aryl group or a group NR3R4 wherein R3 and R4 are as defined in the description, R2 represents an alkyl, (C3-C8)cycloalkyl or (C3-C8)cycloalkyl-(C1-C6)alkyl group, its isomers, and addition salts thereof, and medicinal products containing the same which are useful in treating conditions treatable by antagonists of type H3 central histamine receptors.

    摘要翻译: 选自式(I)的化合物:其中:X表示C(O)或SO 2基团,R 1表示芳基或NR 3 R 4,其中R 3和R 4如说明书中所定义,R 2表示烷基( C 3 -C 8)环烷基或(C 3 -C 8)环烷基 - (C 1 -C 6)烷基,其异构体及其加成盐,以及含有它们的药物,可用于治疗由H3型中枢组胺受体 。

    Benzothiazine and benzothiadiazine compounds
    49.
    发明授权
    Benzothiazine and benzothiadiazine compounds 失效
    苯并噻嗪和苯并噻二嗪化合物

    公开(公告)号:US07423034B2

    公开(公告)日:2008-09-09

    申请号:US11823439

    申请日:2007-06-27

    CPC分类号: C07D513/04

    摘要: Compounds of formula (I): wherein: R1 represents hydrogen, a halogen or alkyl, R1a represents hydrogen or alkyl, R2 represents hydrogen, a halogen or hydroxy, A represents NR4, R3 represents hydrogen, alkyl or cycloalkyl, R4 represents hydrogen or alkyl, X is as defined in the description, their isomers, and also addition salts thereof. Medicinal products containing the same which are useful in treating disorders of the AMPA system.

    摘要翻译: 式(I)的化合物:其中:R 1表示氢,卤素或烷基,R 1a表示氢或烷基,R 2表示 氢,卤素或羟基,A表示NR 4,R 3表示氢,烷基或环烷基,R 4表示氢或烷基,X 如说明书中所定义,它们的异构体及其加成盐。 含有该药物的药物可用于治疗AMPA系统的病症。

    Benzothiadiazine compounds
    50.
    发明授权
    Benzothiadiazine compounds 失效
    苯并噻二嗪化合物

    公开(公告)号:US07268130B2

    公开(公告)日:2007-09-11

    申请号:US11265011

    申请日:2005-11-02

    CPC分类号: C07D285/24

    摘要: The invention relates to compounds of formula (I): wherein: R1 represents alkyl substituted by one or more halogen atoms, R2 represents hydrogen, halogen or hydroxy, R3 represents unsubstituted or substituted aryl, their isomers, and also addition salts thereof. and medicinal products containing the same which are useful in treating or preventing disorders associated with AMPA flux.

    摘要翻译: 本发明涉及式(I)化合物:其中:R 1表示被一个或多个卤素原子取代的烷基,R 2表示氢,卤素或羟基, 表示未取代或取代的芳基,它们的异构体及其加成盐。 以及含有该药物的药物,其可用于治疗或预防与AMPA通量相关的疾病。